MDS Expects Double-Digit Revenue Growth in 2008 | GenomeWeb
NEW YORK (GenomeWeb News) – MDS today announced that it expects to report 2008 revenue growth of between 12 percent and 16 percent.
The Toronto-based firm said its revenues for full-year 2008 should be between $1.35 billion and $1.4 billion, up from $1.2 billion in 2007.
MDS also said it expects to report adjusted EBITDA in the range of $175 million to $185 million and adjusted earnings per share of $.37 to $.43, compared with adjusted EBITDA of $145 million, or $.34 per share, in 2007.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.